Reason for stopping ADA | N | Effect of swapping | N on ongoing IFX therapy | Responders’ median (range) t on IFX (months) |
---|---|---|---|---|
Primary failure | 9 | 6/9 (66%) Achieved response | 5/9 | 8 (3–55) |
3/9 (33%) No response | ||||
Secondary loss of response | 14 | 12/14 (86%) Re-captured response | 11/14 | 24 (4–39) |
2/14 (14%) Not recaptured response | ||||
Intolerance | 3 | 2/3 (66%) Maintained response | 2/3 | 6 (2–9) |
1/3 (33%) Lost response | ||||
Other | 2 | 2/2 (100%) Maintained response | 1 /2 | 13 |
Total | 28 | 22/28 (79%) Positive outcome | 19/28 (68%) | 13 (2–55) |